Multiple Sclerosis Association of America Produces a Monograph on Complementary and Alternative Medicine for the ... U.S. Newswire via Yahoo! News Mon, 29 Jan 2007 10:12 AM PST The Multiple Sclerosis Association of America (MSAA) has produced a monograph titled, Thinking about Complementary and Alternative Medicine? The monograph provides an introduction for people with multiple sclerosis (MS) on how to find and evaluate claims about complementary and alternative medicine (CAM). This is the first of two monographs MSAA is publishing through a grant from Berlex. Both ...

ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy RedNova Mon, 29 Jan 2007 9:15 AM PST Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that ReceptoPharm had commenced its Phase IIb clinical trial in subjects with Adrenomyeloneuropathy (AMN).

Tanabe Resumes MS Drug Study RedNova Mon, 29 Jan 2007 9:16 AM PST Japanese pharmaceutical company Tanabe Seiyaku has resumed a phase II trial of its multiple sclerosis treatment after the FDA released its clinical hold on the study.

A diet of worms could keep MS at bay
New Scientist Sun, 28 Jan 2007 11:27 PM PST
Parasitic worms could improve the prospects of people with autoimmune diseases such as multiple sclerosis

Chopping Off Protein Puts Immune Cells Into High Gear
Medical News Today Mon, 29 Jan 2007 7:01 AM PST
The complex task of launching a well-organized, effective immune system attack on specific targets is thrown into high gear when either of two specific enzymes chop a protein called LAG-3 off the immune cells leading that battle, according to investigators at St. Jude Children's Research Hospital. [click link for full article]

Medical cannabis is a blunt tool New Scientist Sun, 28 Jan 2007 11:37 PM PST Results of clinical trials of cannabis have been mixed and it now seems there are fundamental problems with how our bodies respond to the stuff

Autoimmune Disease Breakthrough Gained By Identification Of 30 Errant Genes Medical News Today Mon, 29 Jan 2007 0:03 AM PST A report in the January issue of Nature magazine announces that one more step in understanding what may cause the body to attack itself in its war against autoimmune disease has been discovered by researchers at the Massachusetts Institute of Technology's Whitehead Institute, says the Autoimmune Related Diseases Association (AARDA), a national nonprofit patient advocacy organization. [click link ...

New Prince Edward Island Research Centre to Play a Critical Role in Advancing Health Care
Government of Canada News Mon, 29 Jan 2007 6:40 AM PST
A new research and service centre made possible by partnerships formed among governments and the private sector is now open for business on the University of Prince Edward Island (UPEI) campus.

When your stock dives for no apparent reason
MSN Money - USA
The company presented at the JPMorgan Healthcare conference two weeks ago and left the overall impression that Tysabri sales were ramping nicely and that an ...

Investors, Caution: Biologics Have Side Effects Too
Seeking Alpha - New York,NY,USA
And when Tysabri was withdrawn, many were stunned that a biologic apparently could have serious side-effects. This may also be one of the reasons why so ...

Infineon, Munich Re, Pernod, Wincor: European Equity Preview
Bloomberg - USA
(ELN ID): The company which reintroduced the Tysabri multiple sclerosis treatment in July is scheduled to release fourth-quarter results. ...